WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H555254
CAS#: 947018-15-7
Description: J9 is a Glucocorticoid resistance inhibitor. J9 Reverses Dexamethasone Resistance in T-cell Acute Lymphoblastic Leukemia (T-ALL).
Hodoodo Cat#: H555254
Name: J9
CAS#: 947018-15-7
Chemical Formula: C12H12N4
Exact Mass: 212.11
Molecular Weight: 212.256
Elemental Analysis: C, 67.90; H, 5.70; N, 26.40
Synonym: J9; J 9; J-9.
IUPAC/Chemical Name: 4-cyclopropyl-5-(pyridin-4-yl)pyrimidin-2-amine
InChi Key: PQLYPFZAOUDDHB-UHFFFAOYSA-N
InChi Code: InChI=1S/C12H12N4/c13-12-15-7-10(8-3-5-14-6-4-8)11(16-12)9-1-2-9/h3-7,9H,1-2H2,(H2,13,15,16)
SMILES Code: NC1=NC=C(C2=CC=NC=C2)C(C3CC3)=N1
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 212.26 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Cantley AM, Welsch M, Ambesi-Impiombato A, Sanchez-Martin M, Kim MY, Bauer A,
Ferrando A, Stockwell BR. Small Molecule that Reverses Dexamethasone Resistance
in T-cell Acute Lymphoblastic Leukemia (T-ALL). ACS Med Chem Lett. 2014 Apr
25;5(7):754-9. doi: 10.1021/ml500044g. eCollection 2014 Jul 10. PubMed PMID:
25050160; PubMed Central PMCID: PMC4094258.